| Type 2 Excludes |
| certain conditions originating in the perinatal period (P04-P96) |
| certain infectious and parasitic diseases (A00-B99) |
| complications of pregnancy, childbirth and the puerperium (O00-O9A) |
| congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) |
| endocrine, nutritional and metabolic diseases (E00-E88) |
| injury, poisoning and certain other consequences of external causes (S00-T88) |
| neoplasms (C00-D49) |
| symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) |
|
G00-G09 |
| Inflammatory diseases of the central nervous system (G00-G09) |
|
G10-G14 |
| Systemic atrophies primarily affecting the central nervous system (G10-G14) |
|
G20-G26 |
| Extrapyramidal and movement disorders (G20-G26) |
|
G30-G32 |
| Other degenerative diseases of the nervous system (G30-G32) |
|
G35-G37 |
| Demyelinating diseases of the central nervous system (G35-G37) |
|
G40-G47 |
| Episodic and paroxysmal disorders (G40-G47) |
|
G50-G59 |
| Nerve, nerve root and plexus disorders (G50-G59) |
|
G60-G65 |
| Polyneuropathies and other disorders of the peripheral nervous system (G60-G65) |
|
G70-G73 |
| Diseases of myoneural junction and muscle (G70-G73) |
|
G80-G83 |
| Cerebral palsy and other paralytic syndromes (G80-G83) |
|
G89-G99 |
| Other disorders of the nervous system (G89-G99) |